Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
- PMID: 32663120
- DOI: 10.1200/JCO.20.01399
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
Abstract
Purpose: To update the ASCO guideline on the recommended prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer survivors.
Methods: An Expert Panel conducted targeted systematic literature reviews to identify new studies.
Results: The search strategy identified 257 new references, which led to a full-text review of 87 manuscripts. A total of 3 systematic reviews, 2 with meta-analyses, and 28 primary trials for prevention of CIPN in addition to 14 primary trials related to treatment of established CIPN, are included in this update.
Recommendations: The identified data reconfirmed that no agents are recommended for the prevention of CIPN. The use of acetyl-l-carnitine for the prevention of CIPN in patients with cancer should be discouraged. Furthermore, clinicians should assess the appropriateness of dose delaying, dose reduction, substitutions, or stopping chemotherapy in patients who develop intolerable neuropathy and/or functional impairment. Duloxetine is the only agent that has appropriate evidence to support its use for patients with established painful CIPN. Nonetheless, the amount of benefit from duloxetine is limited.Additional information is available at www.asco.org/survivorship-guidelines.
Similar articles
-
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.J Clin Oncol. 2014 Jun 20;32(18):1941-67. doi: 10.1200/JCO.2013.54.0914. Epub 2014 Apr 14. J Clin Oncol. 2014. PMID: 24733808 Review.
-
Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN).Cancer Treat Rev. 2021 Sep;99:102241. doi: 10.1016/j.ctrv.2021.102241. Epub 2021 Jun 9. Cancer Treat Rev. 2021. PMID: 34174668 Review.
-
A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms.J Cancer Surviv. 2023 Feb;17(1):254-277. doi: 10.1007/s11764-021-00997-w. Epub 2021 Mar 12. J Cancer Surviv. 2023. PMID: 33710510 Free PMC article. Review.
-
Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.Support Care Cancer. 2018 Apr;26(4):1051-1059. doi: 10.1007/s00520-017-4028-6. Epub 2017 Dec 26. Support Care Cancer. 2018. PMID: 29280005
-
Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations.Pain Physician. 2018 Nov;21(6):571-592. Pain Physician. 2018. PMID: 30508986
Cited by
-
Mindfulness is associated with severity of peripheral neuropathy and related patient-reported outcomes among colorectal cancer patients.Support Care Cancer. 2022 Nov;30(11):9517-9526. doi: 10.1007/s00520-022-07340-8. Epub 2022 Aug 28. Support Care Cancer. 2022. PMID: 36030458 Free PMC article.
-
Development and validation of the chemotherapy-induced peripheral neuropathy integrated assessment - oxaliplatin subscale: a prospective cohort study.BMC Cancer. 2023 Nov 14;23(1):1109. doi: 10.1186/s12885-023-11541-7. BMC Cancer. 2023. PMID: 37964212 Free PMC article.
-
Study on the Efficacy and Safety of the Huangqi Guizhi Wuwu Decoction in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Meta-Analysis of 32 Randomized Controlled Trials.J Pain Res. 2024 Aug 8;17:2605-2628. doi: 10.2147/JPR.S466658. eCollection 2024. J Pain Res. 2024. PMID: 39139997 Free PMC article. Review.
-
Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study.J Transl Med. 2022 Dec 6;20(1):564. doi: 10.1186/s12967-022-03754-4. J Transl Med. 2022. PMID: 36474270 Free PMC article.
-
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)-a white paper.Support Care Cancer. 2024 Jan 20;32(2):117. doi: 10.1007/s00520-023-08301-5. Support Care Cancer. 2024. PMID: 38244122 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical